Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: An early sign of cardiac involvement

K. Nakajima, J. Taki, M. Kawano, T. Higuchi, S. Sato, C. Nishijima, K. Takehara, N. Tonami

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Diagnosis of cardiac involvement is important for the management of patients with systemic sclerosis (SSc). This study was undertaken to determine the significance of gated myocardial perfusion SPECT in patients with SSc and whether diastolic function measured by gated SPECT is an early sign of cardiac complications. Methods: Thirty-four patients with SSc and 16 control patients were studied using exercise nongated and resting gated myocardial perfusion SPECT. The SSc was classified by the modified Rodnan total skin score (TSS) into high-TSS (score ≥ 10; n = 18) and low-TSS (score < 10; n = 16) groups. Gated SPECT was performed using 99mTc-methoxyisobutyl-isonitrile with 16 frames per cardiac cycle and quantitatively analyzed by QGS software and Fourier filtering of the volume curve. The parameters of ejection fraction (EF), peak filling rate (PFR), one-third mean filling rate, and time to PFR (TPFR) were calculated. Results: A slight perfusion abnormality was observed in four and five patients in the low-TSS and high-TSS groups, respectively (not statistically significant). A decreased resting EF less than 55% was found in no and two patients in the low-TSS and high-TSS groups, respectively. TPFR was 166 ± 22, 168 ± 38, and 216 ± 82 ms (P = 0.05, high-TSS group versus low-TSS group; P = 0.04, control group versus high-TSS group) and TPFR/R-R interval was 0.18 ± 0.02, 0.19 ± 0.04, and 0.26 ± 0.09 (P = 0.01, high-TSS group versus low-TSS group; P = 0.005, control group versus high-TSS group) for the control, low-TSS, and high-TSS groups, respectively. Conclusion: Diastolic function can be evaluated by gated myocardial perfusion SPECT. Significant diastolic abnormalities were shown even in patients with normal perfusion and systolic function and were related to the severity of SSc.

Original languageEnglish
Pages (from-to)183-188
Number of pages6
JournalJournal of Nuclear Medicine
Volume42
Issue number2
Publication statusPublished - Feb 24 2001
Externally publishedYes

Fingerprint

Systemic Scleroderma
Single-Photon Emission-Computed Tomography
Perfusion
Skin
Control Groups

Keywords

  • Tc-methoxyisobutylisonitrile
  • Diastolic function
  • Gated SPECT
  • Skin score
  • Systemic sclerosis

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT : An early sign of cardiac involvement. / Nakajima, K.; Taki, J.; Kawano, M.; Higuchi, T.; Sato, S.; Nishijima, C.; Takehara, K.; Tonami, N.

In: Journal of Nuclear Medicine, Vol. 42, No. 2, 24.02.2001, p. 183-188.

Research output: Contribution to journalArticle

Nakajima, K, Taki, J, Kawano, M, Higuchi, T, Sato, S, Nishijima, C, Takehara, K & Tonami, N 2001, 'Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: An early sign of cardiac involvement', Journal of Nuclear Medicine, vol. 42, no. 2, pp. 183-188.
Nakajima, K. ; Taki, J. ; Kawano, M. ; Higuchi, T. ; Sato, S. ; Nishijima, C. ; Takehara, K. ; Tonami, N. / Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT : An early sign of cardiac involvement. In: Journal of Nuclear Medicine. 2001 ; Vol. 42, No. 2. pp. 183-188.
@article{47a1fc9afe004dfcbf5f144a826c765c,
title = "Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: An early sign of cardiac involvement",
abstract = "Diagnosis of cardiac involvement is important for the management of patients with systemic sclerosis (SSc). This study was undertaken to determine the significance of gated myocardial perfusion SPECT in patients with SSc and whether diastolic function measured by gated SPECT is an early sign of cardiac complications. Methods: Thirty-four patients with SSc and 16 control patients were studied using exercise nongated and resting gated myocardial perfusion SPECT. The SSc was classified by the modified Rodnan total skin score (TSS) into high-TSS (score ≥ 10; n = 18) and low-TSS (score < 10; n = 16) groups. Gated SPECT was performed using 99mTc-methoxyisobutyl-isonitrile with 16 frames per cardiac cycle and quantitatively analyzed by QGS software and Fourier filtering of the volume curve. The parameters of ejection fraction (EF), peak filling rate (PFR), one-third mean filling rate, and time to PFR (TPFR) were calculated. Results: A slight perfusion abnormality was observed in four and five patients in the low-TSS and high-TSS groups, respectively (not statistically significant). A decreased resting EF less than 55{\%} was found in no and two patients in the low-TSS and high-TSS groups, respectively. TPFR was 166 ± 22, 168 ± 38, and 216 ± 82 ms (P = 0.05, high-TSS group versus low-TSS group; P = 0.04, control group versus high-TSS group) and TPFR/R-R interval was 0.18 ± 0.02, 0.19 ± 0.04, and 0.26 ± 0.09 (P = 0.01, high-TSS group versus low-TSS group; P = 0.005, control group versus high-TSS group) for the control, low-TSS, and high-TSS groups, respectively. Conclusion: Diastolic function can be evaluated by gated myocardial perfusion SPECT. Significant diastolic abnormalities were shown even in patients with normal perfusion and systolic function and were related to the severity of SSc.",
keywords = "Tc-methoxyisobutylisonitrile, Diastolic function, Gated SPECT, Skin score, Systemic sclerosis",
author = "K. Nakajima and J. Taki and M. Kawano and T. Higuchi and S. Sato and C. Nishijima and K. Takehara and N. Tonami",
year = "2001",
month = "2",
day = "24",
language = "English",
volume = "42",
pages = "183--188",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "2",

}

TY - JOUR

T1 - Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT

T2 - An early sign of cardiac involvement

AU - Nakajima, K.

AU - Taki, J.

AU - Kawano, M.

AU - Higuchi, T.

AU - Sato, S.

AU - Nishijima, C.

AU - Takehara, K.

AU - Tonami, N.

PY - 2001/2/24

Y1 - 2001/2/24

N2 - Diagnosis of cardiac involvement is important for the management of patients with systemic sclerosis (SSc). This study was undertaken to determine the significance of gated myocardial perfusion SPECT in patients with SSc and whether diastolic function measured by gated SPECT is an early sign of cardiac complications. Methods: Thirty-four patients with SSc and 16 control patients were studied using exercise nongated and resting gated myocardial perfusion SPECT. The SSc was classified by the modified Rodnan total skin score (TSS) into high-TSS (score ≥ 10; n = 18) and low-TSS (score < 10; n = 16) groups. Gated SPECT was performed using 99mTc-methoxyisobutyl-isonitrile with 16 frames per cardiac cycle and quantitatively analyzed by QGS software and Fourier filtering of the volume curve. The parameters of ejection fraction (EF), peak filling rate (PFR), one-third mean filling rate, and time to PFR (TPFR) were calculated. Results: A slight perfusion abnormality was observed in four and five patients in the low-TSS and high-TSS groups, respectively (not statistically significant). A decreased resting EF less than 55% was found in no and two patients in the low-TSS and high-TSS groups, respectively. TPFR was 166 ± 22, 168 ± 38, and 216 ± 82 ms (P = 0.05, high-TSS group versus low-TSS group; P = 0.04, control group versus high-TSS group) and TPFR/R-R interval was 0.18 ± 0.02, 0.19 ± 0.04, and 0.26 ± 0.09 (P = 0.01, high-TSS group versus low-TSS group; P = 0.005, control group versus high-TSS group) for the control, low-TSS, and high-TSS groups, respectively. Conclusion: Diastolic function can be evaluated by gated myocardial perfusion SPECT. Significant diastolic abnormalities were shown even in patients with normal perfusion and systolic function and were related to the severity of SSc.

AB - Diagnosis of cardiac involvement is important for the management of patients with systemic sclerosis (SSc). This study was undertaken to determine the significance of gated myocardial perfusion SPECT in patients with SSc and whether diastolic function measured by gated SPECT is an early sign of cardiac complications. Methods: Thirty-four patients with SSc and 16 control patients were studied using exercise nongated and resting gated myocardial perfusion SPECT. The SSc was classified by the modified Rodnan total skin score (TSS) into high-TSS (score ≥ 10; n = 18) and low-TSS (score < 10; n = 16) groups. Gated SPECT was performed using 99mTc-methoxyisobutyl-isonitrile with 16 frames per cardiac cycle and quantitatively analyzed by QGS software and Fourier filtering of the volume curve. The parameters of ejection fraction (EF), peak filling rate (PFR), one-third mean filling rate, and time to PFR (TPFR) were calculated. Results: A slight perfusion abnormality was observed in four and five patients in the low-TSS and high-TSS groups, respectively (not statistically significant). A decreased resting EF less than 55% was found in no and two patients in the low-TSS and high-TSS groups, respectively. TPFR was 166 ± 22, 168 ± 38, and 216 ± 82 ms (P = 0.05, high-TSS group versus low-TSS group; P = 0.04, control group versus high-TSS group) and TPFR/R-R interval was 0.18 ± 0.02, 0.19 ± 0.04, and 0.26 ± 0.09 (P = 0.01, high-TSS group versus low-TSS group; P = 0.005, control group versus high-TSS group) for the control, low-TSS, and high-TSS groups, respectively. Conclusion: Diastolic function can be evaluated by gated myocardial perfusion SPECT. Significant diastolic abnormalities were shown even in patients with normal perfusion and systolic function and were related to the severity of SSc.

KW - Tc-methoxyisobutylisonitrile

KW - Diastolic function

KW - Gated SPECT

KW - Skin score

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0035122465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035122465&partnerID=8YFLogxK

M3 - Article

C2 - 11216514

AN - SCOPUS:0035122465

VL - 42

SP - 183

EP - 188

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 2

ER -